In vasculitic kidney disease, the tubules are injured where the T cells are

Design

imaging mass cytometry of kidney biopsy samples at single-cell resolution with unbiased clustering and spatial analysis

Population

15 patients — 5 ANCA-associated vasculitis, 5 class III/IV lupus nephritis, 5 reference; 106,455 cells analysed

Primary outcome

expression and spatial distribution of injury markers in resident kidney cells

Effect

pRIPK3 and FACL4 upregulated in multiple tubule segments and endothelial cells in both diseases, concentrated in cells immediately adjacent to immune cells, particularly T cells

Tubulointerstitial damage predicts progression to kidney failure in both ANCA-associated vasculitis and lupus nephritis better than glomerular findings do, and yet treatment in both diseases is aimed at the glomerulus. This study took biopsies from 15 patients — five with ANCA-associated vasculitis, five with class III or IV lupus nephritis, five reference samples from non-tumour regions of nephrectomies — and analysed 106,455 individual cells by imaging mass cytometry, which preserves where each cell sat.

Resident tubular and endothelial cells in both diseases showed loss of differentiation markers and upregulation of two injury proteins: phosphorylated RIPK3, a kinase central to necroptosis, and FACL4, a fatty acid ligase associated with ferroptosis. Both mark regulated cell death pathways distinct from apoptosis.

The spatial finding is what imaging mass cytometry adds. These injury markers were concentrated in resident cells immediately adjacent to infiltrating immune cells, and T cells in particular. That is a direct observation of a mechanism that has been inferred — immune cells damaging tubules by contact rather than through circulating mediators — and it points at necroptosis and ferroptosis as the routes. The authors call it hypothesis-generating, which with five patients per group is the correct description.

• Nothing here changes treatment; necroptosis and ferroptosis inhibitors are not available for clinical use.
• The clinically useful reminder is that tubulointerstitial damage drives prognosis in these diseases and should be read carefully on the biopsy report.
• Reference samples were non-tumour regions of nephrectomy specimens, which is the best available control but is not normal kidney.
• T cell-adjacent injury is consistent with why T cell-directed therapy works in lupus nephritis, and raises the same question for ANCA-associated vasculitis.
• Five patients per group means these are observations, not prevalence estimates.

Why it matters

It locates the injury that determines prognosis in these diseases next to the immune cells current treatment already targets, which is an argument for treating earlier rather than differently.

Don't overread it

Fifteen biopsies with five per group and nephrectomy tissue as reference — this is a descriptive, hypothesis-generating study with no outcome data.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.